8.750EUR+1.51%Mkt Cap: 63.31M EURP/E: 109.38Last update: 2026-05-29
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company offers non-invasive brain s…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap63.31M EUR
Enterprise Value64.64M EUR
Revenue (TTM)12.41M EUR
Gross Profit9.90M EUR
Net Income (TTM)573.20K EUR
Revenue/Share1.732 EUR
Last Price8.750 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees40
CountryFI
SectorHealthcare
IndustryMedical Devices
ISINFI4000506811
Valuation
P/E (Trailing)109.38
P/E (Forward)32.44
PEG—
EV/EBITDA74.21
EV/Revenue5.21
P/S5.11
P/B15.10
EPS (TTM)0.08
EPS (Forward)0.27
52W Range
7.78011% of range16.45
52W High16.45 EUR
52W Low7.780 EUR
Profitability
Gross Margin90.29%
Oper. Margin12.53%
EBITDA Margin7.02%
Profit Margin5.23%
ROE13.71%
ROA4.35%
Growth
Revenue Growth12.50%
Earnings Growth821.70%
Cash Flow & Leverage
Operating CF1.67M EUR
CapEx (TTM)1.70M EUR
FCF Margin-1.14%
FCF Yield-0.22%
Net Debt1.45M EUR
Net Debt/EBITDA1.67
Balance Sheet
Debt/Equity0.99
Current Ratio1.27
Quick Ratio1.10
Book Value/Sh0.5800 EUR
Cash/Share0.3710 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateMay 17, 2021
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)11.00 EUR
Target Range11.00 EUR – 11.00 EUR
# Analysts1
Ownership
Shares Out.7.23M
Float4.26M
Insiders41.80%
Institutions0.18%
Technical
SMA 508.969 (-2.4%)
SMA 20012.19 (-28.2%)
Beta0.45
S&P 52W Chg27.94%
Avg Vol (30d)4.42K
Avg Vol (10d)4.81K
Technical Indicators
RSI (14)41.6
MACD-0.1232
MACD Signal-0.0840
MACD Hist.-0.0392
BB Upper9.616 EUR
BB Middle8.911 EUR
BB Lower8.206 EUR
BB Width15.82%
ATR (14)0.4009 EUR
Vol Ratio (20d)0.26x